ArticleLiver cancer2026

Reply to "Methodological Concerns in 'Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma'".

Da-Long Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.